Inventor
RUEEGER HEINRICH
CH25 patents
⚠️ This page may combine multiple inventors who share the name “RUEEGER HEINRICH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
7 patentsUS5719141AFeb 17, 1998
2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amide derivatives
NOVARTIS AG18 citations82
US8865894B2Oct 21, 2014
Oxazolidin-2-one compounds and uses thereof
NOVARTIS AG10 citations81
US10301296B2May 28, 2019
Heterocyclic derivatives and their use in the treatment of neurological disorders
NOVARTIS AG1 citations71
US10035794B2Jul 31, 2018
Heterocyclic derivatives and their use in the treatment of neurological disorders
NOVARTIS AG3 citations71
US10683287B2Jun 16, 2020
Heterocyclic derivatives and their use in the treatment of neurological disorders
NOVARTIS AG0 citations51
US10202371B2Feb 12, 2019
Oxazolidin-2-one-pyrimidine derivatives and the use thereof as phosphatidylinositol-3-kinase inhibitors
NOVARTIS AG0 citations47
US7910774B2Mar 22, 2011
Alternative synthesis of renin inhibitors and intermediates thereof
NOVARTIS AG0 citations46
BADIGER SANGAMESH
3 patentsUS8637508B2Jan 28, 2014
Heterocyclic derivatives and their use in the treatment of neurological disorders
BADIGER SANGAMESH75 citations95
US9550758B2Jan 24, 2017
Heterocyclic derivatives and their use in the treatment of neurological disorders
BADIGER SANGAMESH4 citations82
US8865712B2Oct 21, 2014
Heterocyclic derivatives and their use in the treatment of neurological disorders
BADIGER SANGAMESH7 citations82
CIBA GEIGY CORP
3 patentsUS4758584AJul 19, 1988
Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by sulphur-containing groups
CIBA GEIGY CORP21 citations81
US4914129AApr 3, 1990
Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by sulphur-containing groups
CIBA GEIGY CORP14 citations73
US4889869ADec 26, 1989
Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by sulphur-containing groups
CIBA GEIGY CORP2 citations62
BLANK JUTTA
3 patentsUS9890166B2Feb 13, 2018
Imidazopyrrolidine derivatives and their use in the treatment of disease
BLANK JUTTA0 citations35
US9624247B2Apr 18, 2017
Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease
BLANK JUTTA0 citations35
US9714249B2Jul 25, 2017
Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease
BLANK JUTTA0 citations34